Ovagen is a tripeptide bioregulator peptide comprised of the sequence Glu-Asp-Leu (EDL), designed to regulate liver and gastrointestinal (GI) tract function. It should not be confused with the similarly named ovine follicle stimulating hormone (FSH) product also called Ovagen. Unlike the FSH derivative which promotes ovulation, this Ovagen peptide acts as a tissue-specific bioregulator with effects on DNA transcription and cellular rejuvenation, particularly in the liver and digestive system.
What is Ovagen?
Developed by Dr. Vladimir Khavinson, a foremost researcher in peptide bioregulators, Ovagen crosses cellular and nuclear membranes to influence gene expression directly. By reversing age-related DNA condensation and restoring youthful transcription patterns, Ovagen enhances cell function and reduces senescence in target tissues.
Key Benefits and Research Highlights
Liver Health and Regeneration: Ovagen stimulates liver cell proliferation and prevents fibrosis and scarring that contributes to liver cirrhosis. It helps maintain liver architecture and function, especially important in aging or damaged liver tissue.
Gastrointestinal Mucosal Protection: Ovagen supports the integrity of the GI mucosal barrier, reducing the adverse effects of antibiotics, environmental toxins, chemotherapy, and malnutrition on the digestive tract.
Anti-Aging Effects: By modifying DNA structure in liver fibroblasts and GI mucosal cells, Ovagen promotes youthful cellular function, improving tissue resilience and reducing chronic inflammation associated with aging.
HIV Research: Ovagen has been identified as one of the smallest and most potent inhibitors of HIV-1 protease, an enzyme critical for viral replication. This highly water-soluble peptide inhibits HIV protease at low concentrations, making it a subject of interest in HIV research.
Molecular and Product Information
Amino Acid Sequence: Glu-Asp-Leu (EDL)
Molecular Formula: C15H25N3O8
Molecular Weight: 375.37 g/mol
Synonyms: EDL, glutamyl-aspartyl-leucine
Purity: Research-grade peptide, high purity
Form: Lyophilized powder for laboratory use
Storage: Store in a cool, dry place per research laboratory standards
Research Applications
Ovagen’s liver and GI targeted effects position it as a potential candidate for therapies addressing inflammation, fibrosis, and toxicity in these tissues. Its anti-HIV activity is under scientific investigation, expanding its relevance beyond bioregulation into antiviral research.
Compliance Disclaimer
Ovagen 20mg from PeptidesAlpha is intended for in-vitro laboratory research only. It is not approved for human or animal use, nor for medical treatment or diagnosis. All use must comply with regulatory standards and is restricted to research settings.
**PeptidesAlpha offers Ovagen peptides of the highest quality to support innovative biomedical and antiviral research endeavors.
Ovagen 20mg
- Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
- The peptide is typically administered via subcutaneous injection.
- The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
- As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
- It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.